1. Spichler, A, Hurwitz, BL, Armstrong, DG, Lipsky, B. Microbiology of diabetic foot infections: from louis pasteur to crime scene investigation. BMC Med. 2015;13(2):1‐13.
Google Scholar | Medline2. Kennon, B, Leese, GP, Cochrane, L, et al. Reduced incidence of lowerextremity amputations in people with diabetes in scotland: a nationwide study. Diabetes Care. 2012;35(12):2588‐2590.
Google Scholar | Crossref | Medline | ISI3. Lai, Y, Gallo, RL. AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense. Trends Immunol. 2009;30(3):131‐141.
Google Scholar | Crossref | Medline4. Schittek, B, Hipfel, R, Sauer, B, et al. Dermcidin:a novel human antibiotic peptide secreted by sweat glands. Nat Immunol. 2001;2(12):1133‐1137.
Google Scholar | Crossref | Medline | ISI5. Wang, X, Preston III, JF, Romeo, T. The pgaABCD locus of Escherichia coli promotes the synthesis of a polysaccharide adhesin required for biofilm formation. J Bacteriol. 2004;186(9):2724‐2734.
Google Scholar | Crossref | Medline6. Rieg, S, Garbe, C, Sauer, B, Kalbacher, H, Schittek, B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol. 2004;151(3):534‐539.
Google Scholar | Crossref | Medline7. Shichiri, M, Ishimaru, S, Ota, T, Nishikawa, T, Isogai, T, Hirata, Y. Salusins: newly identified bioactive peptides with hemodynamic and mitogenic activities. Nat Med. 2003;9(9):1166‐1172.
Google Scholar | Crossref | Medline | ISI8. Sato, K, Fujimoto, K, Koyama, T, Shichiri, M. Release of salusin-beta from human monocytes/macro­phages. Regul Pept. 2010;162(1-3):68‐72.
Google Scholar | Crossref | Medline9. Sato, K, Koyama, T, Tateno, T, Hirata, Y, Shichiri, M. Presence of immunoreactive salusin-alpha in human serum and urine. Peptides. 2006;27(11):2561‐2566.
Google Scholar | Crossref | Medline | ISI10. Sato, K, Sato, T, Susumu, T, et al. Presence of immunoreactive salusin-beta in hu­man plasma and urine. Regul Pept. 2009;158(1-3):63‐67.
Google Scholar | Crossref | Medline11. Kimura, M, Shindo, M, Moriizumi, T, et al. Salusin-β, an antimicrobially active peptide against gram-positive Bacteria. Chem Pharm Bull (Tokyo). 2014;62(6):586‐590.
Google Scholar | Crossref | Medline | ISI12. Edmonds, M, Foster, A. The use of antibiotics in the diabetic foot. Am J Surg. 2004;187(5A):25‐28.
Google Scholar | Crossref | Medline | ISI13. Lai, YP, Peng, YF, Zuo, Y, et al. Functional and structural characterization of recombinant dermcidin-1L, a human antimicrobial peptide. Biochem Biophys Res Commun. 2005;328(1):243‐250.
Google Scholar | Crossref | Medline14. Burian, M, Schittek, B. The secrets of dermcidin action. Int J Med Microbiol. 2015;305(2):283‐286.
Google Scholar | Crossref | Medline15. Gomes, A, Teixeira, C, Ferraz, R, Prudêncio, C, Gomes, P. Wound-healing peptides for treatment of chronic diabetic foot ulcers and other infected skin injuries. Molecules. 2017;22(10):1743.
Google Scholar | Crossref16. Steinstraesser, L, Hirsch, T, Schulte, M, et al. Innate defense regulator peptide 1018 in wound healing and wound infection. PLoS ONE. 2012;8:2‐6.
Google Scholar17. Duplantier, AJ, Van Hoek, ML. The human cathelicidin antimicrobial peptide ll-37 as a potential treatment for polymicrobial infected wounds. Front Immunol. 2013;3(4):143.
Google Scholar18. Argun, D, Argun, F, Borku Uysal, B. Evaluation of salusin-α and salusin-β levels in patients with type 2 diabetes mellitus and determination of the impact of severity of hyperglycemia on salusin levels. Ir J Med Sci. 2021 Nov;190(4):1403‐1411. doi: 10.1007/s11845-021-02674-4. Epub 2021 Jun 9. PMID: 34109528.
Google Scholar | Crossref | Medline19. Sipahi, S, Genc, AB, Acikgoz, SB, et al. Relationship of salusin-alpha and salusin-beta levels with atherosclerosis in patients undergoing haemodialysis. Singapore Med J. 2019;60(4):210‐215. doi:10.11622/smedj.2018123
Google Scholar | Crossref | Medline20. Xie, F, Chai, C, Li, D, Yang, W, Lu, Y, Cao, N. The time changes of endogenous salusin-β in septic rats. European Journal of Inflammation. 2017;15(1):15‐27.
Google Scholar | SAGE Journals | ISI21. Uğur, K, Aydın, S, Sener, SY, Yıldırım, K, Özkan, Y. Serum apelin, salusin- α and salusin- β levels in type 2 diabetes mellitus and hypertension. Endocrine Abstracts. 2015;37 :EP332.
Google Scholar22. Aydin, S, Celik, O, Gurates, B, et al. Concentrations of preptin, salusins and hepcidins in plasma and milk of lactating women with or without gestational diabetes mellitus. Peptides. 2013;49:123‐130.
Google Scholar | Crossref | Medline | ISI23. Aydin, S, Aydin, S. Salusin-alpha and -beta expression in heart and aorta with and without metabolic syndrome. Biotech Histochem. 2014;89(2):98‐103.
Google Scholar | Crossref | Medline24. Zhao, MX, Zhou, B, Ling, L, et al. Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy. Cell Death and Disease. 2017;8(3):e2690.
Google Scholar | Crossref | Medline25. Sun, HJ, Chen, D, Wang, PY, et al. Salusin-β is involved in diabetes mellitus-induced endothelial dysfunction via degradation of peroxisome proliferator-activated receptor gamma. Oxid Med Cell Longevity. 2017;2017:6905217.
Google Scholar | Crossref | Medline